References
- Gaucher G, Dufresne MH, Sant VP, et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005;109:169–88
- Haque S, Md S, Alam MI, et al. Nanostructure-based drug delivery systems for brain targeting. Drug Dev Ind Pharm 2012;38:387–411
- Liang H, Yang Q, Deng L, et al. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm 2011;37:597–605
- Mahmud A, Xiong XB, Aliabadi HM, Lavasanifar A. Polymeric micelles for drug targeting. J Drug Target 2007;15:553–84
- Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113–31
- Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24:1–16
- Zhao Y, Li Y, Ge J, et al. Pluronic-poly (acrylic acid)-cysteine/pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel. Drug Dev Ind Pharm 2013. [Epub ahead of print]
- Hong JW, Park JH, Huh KM, et al. PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system. J Control Rel 2004;99:167–76
- Wang Y, Ke CY, Weijie Beh C, et al. The self-assembly of biodegradable cationic polymer micelles as vectors for gene transfection. Biomaterials 2007;28:5358–68
- Oikawa Y, Lee S, Kim do H, et al. One-pot synthesis of linear-hyperbranched amphiphilic block copolymers based on polyglycerol derivatives and their micelles. Biomacromolecules 2013;14:2171–8
- Ouahab A, Shao C, Shen Y, Tu J. Development and characterization of stabilized double loaded mPEG-PDLLA micelles for simultaneous delivery of paclitaxel and docetaxel. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.788017
- Nasongkla N, Bey E, Ren J, et al. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett 2006;6:2427–30
- Francis MF, Cristea M, Yang Y, Winnik FM. Engineering polysaccharide-based polymeric micelles to enhance permeability of cyclosporin A across Caco-2 cells. Pharmaceut Res 2005;22:209–19
- Hassani LN, Hendra F, & Bouchemal K. Auto-associative amphiphilic polysaccharides as drug delivery systems. Drug Discov Today 2012;17:608–14
- Kumar MN, Muzzarelli RA, Muzzarelli C, et al. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004;104:6017–84
- Lee CM, Park JW, Kim J, et al. Influence of histidine on the release of all-trans retinoic acid from self-assembled glycol chitosan nanoparticles. Drug Dev Ind Pharm 2010;36:781–6
- Zhang J, Xia W, Liu P, et al. Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 2010;8:1962–87
- Liu X, Ma L, Mao Z, Gao C. Chitosan-based biomaterials for tissue repair and regeneration. Adv Polymer Sci 2011;244:81–128
- Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 2005;10:1451–8
- Ryan SM, Mantovani G, Wang X, et al. Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv 2008;5:371–83
- Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2003;2:214–21
- Bailon P, Won CY. PEG-modified biopharmaceuticals. Expert Opini Drug Deliv 2009;6:1–16
- Veronese FM, Mero A. The impact of PEGylation on biological therapies. BioDrugs 2008;22:315–29
- Pasut G, Veronese FM. PEG conjugates in clinical development or use as anticancer agents: an overview. Adv Drug Deliv Rev 2009;61:1177–88
- Yue-Jian C, Juan T, Fei X, et al. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev Ind Pharm 2010;36:1235–44
- Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 2002;54:459–76
- Opanasopit P, Ngawhirunpat T, Rojanarata T, et al. Camptothecin-incorporating N-phthaloylchitosan -g-mPEG self-assembly micellar system: effect of degree of deacetylation. Colloids Surf B Biointerfaces 2007;60:117–24
- Sezgin Z, Yüksel N, Baykara T. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 2006;64:261–8
- Opanasopit P, Yokoyama M, Watanabe M, et al. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res 2004;21:2001–8
- Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008;5:496–504
- Zhou JC, Zhuang DQ, Yuan XF, et al. Association of fluorocarbon and hydrocarbon end-capped poly(ethylene glycol)s: 1H-NMR and fluorescence studies. Langmuir 2000;16:9653–61
- Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv 2010;7:1063–77
- Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clinical Cancer Res 2008;14:1310–16
- Kwon S, Park JH, Chung H, et al. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5-cholanic acid. Langmuir 2003;19:10188–93
- Huo M, Zou A, Yao C, et al. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles. Biomaterials 2012;33:6393–407
- Mu CF, Balakrishnan P, Cui FD, et al. The effects of mixed MPEG-PLA/pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 2010;31:2371–9
- Tong SW, Xiang B, Dong DW, Qi XR. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Int J Pharm 2012;434:413–19
- Rauth AM, Mohindra JK, Tannock IF. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res 1983;43:4154–8
- Rockwell S, Hughes CS. Effects of mitomycin C and porfiromycin on exponentiallygrowing and plateau phase cultures. Cell Prolif 1994;27:153–63
- Cheung RY, Ying Y, Rauth AM, et al. Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. Biomaterials 2005;26:5375–85
- Hou Z, Li Y, Huang Y, et al. Phytosomes loaded with mitomycin C-soybean phosphatidylcholine complex developed for drug delivery. Mol Pharm 2013;10:90–101